FDA Maintains Pressure Against Adulterated ED Supplements

FDA says its seizure of $74,000 in mislabeled erectile dysfunction supplements from SEI Pharmaceuticals July 24 demonstrates the steps the agency will take when a company fails to heed a warning about an allegedly adulterated product

More from Archive

More from Pink Sheet